• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Unified Financial Management System (UFMS) Budget Execution Module Upgrade (1)

Description: The Office of Financial Management (OFM) is upgrading the current Budget Execution Module in UFMS. As part of this upgrade, OFM is designing and development a new web-based front end for the Oracle Budget Execution Module. These forms will apply the latest Oracle technology and financial management procedures to improve the Division of Budget Execution and Control’s (DBEC’s) ability to monitor and track funds. They will allow for the allocation of funds, the monitoring and tracking of Continuing Resolutions, and provide accounting data for all transactions, reporting, and transfers. The enhancement will be implemented in a phased approach.

Phase I provides the DBEC Budget Analysts a user-friendly form to enter Budget Resources, Apportionments, Allotments, and Allowances. Phase II automates the current DBEC budget procedures for allocating and moving resources.

Accomplishment: Completion of the implementation of Phase II of the Budget Execution Module upgrade will allow the FDA to improve the management of financial resources. Instead of processing the movement and allocation of funds manually, this new process allows the movement of these funds through an automated process with minimal manual entry on the front end. This new process will improve the timeliness of moving and allocating budget resources by the Office of Financial Management’s Division of Budget Execution and Control (DBEC). Additionally, the improvement in this process will give each FDA program up to date budget data to meet FDA’s managerial reporting needs.

Briefing Status: COMPLETED

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Complete requirements gathering for Phase II

9/1/2011

Completed 10/21/2011

B. Train Users for Phase I

10/1/2011

Completed 10/12/2011

C. Implement Phase I in Production

10/1/2011

Completed 10/1/2011

D. Begin development of Phase II

11/1/2011

Completed 9/26/2011

E. Complete development of Phase II

1/1/2012

(1/27/2012)

Completed 2/10/2012

F. Integration testing for Phase II

2/1/2012

Completed 2/24/2012

G. Regression testing for Phase II

3/1/2012

Completed 3/1/2012

H. User Acceptance testing for Phase II

3/1/2012

Completed 3/9/2012

I. Train users for Phase II

3/1/2012

Completed 3/27/2012

J. Implement Phase II in Production

4/1/2012

Completed 3/19/2012

Footnotes

  • (1) The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.